BioNTech ensures that its vaccine is ‘effective’ against the Omicron variant after ‘three doses’
The coronavirus vaccine developed by the Pfizer and BioNTech laboratories is “effective” against the Omicron variant after “three doses,” BioNTech said in a statement this Wednesday, December 8, that it wishes to